Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma-Reference-Cited by-同舟云学术

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma

Published:2017-09-23 Issue:2 Volume:73 Page:490-497
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Casale T. B.¹^ORCID,Chipps B. E.²,Rosén K.³,Trzaskoma B.³,Haselkorn T.⁴,Omachi T. A.³,Greenberg S.⁵⁶,Hanania N. A.⁷

Affiliation:

1. Division of Allergy and Immunology; University of South Florida; Tampa FL USA

2. Capital Allergy & Respiratory Disease Center; Sacramento CA USA

3. Genentech, Inc.; South San Francisco CA USA

4. EpiMetrix, Inc.; Los Altos CA USA

5. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

6. Department of Medicine; College of Physicians and Surgeons; Columbia University; New York NY USA

7. Section of Pulmonary and Critical Care Medicine; Asthma Clinical Research Center; Baylor College of Medicine; Houston TX USA

Funder

Novartis Pharma

Genentech

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13302/fullpdf

Reference36 articles.

1. Xolair [package insert] South San Francisco, CA Genentech USA, Inc. 2016

2. European Medicines Agency Xolair summary of product characteristics 2016 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000606/WC500057298.pdf

3. High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects;Busse;J Allergy Clin Immunol,2013

4. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials;Castro;Lancet Respir Med,2015

5. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study;Hanania;Am J Respir Crit Care Med,2013

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Advancements in biologic therapy in eosinophilic asthma;Expert Opinion on Biological Therapy;2024-04-02

3. The Incredible Adventure of Omalizumab;International Journal of Molecular Sciences;2024-03-06

4. Association of serum YKL-40 and DPP4 with T2-high asthma in Chinese adults;Medicine;2024-02-09

5. Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe Asthma;Internal Medicine;2024-01-15